Cat. #154000
Anti-CEACAM1/3/5/6 (CD66a/d/e/c) [D2-4H]
Cat. #: 154000
Sub-type: Primary antibody
Unit size: 100 ug
Availability: 10-12 weeks
Target: Human CEACAM 1, 3, 4, 6
Class: Monoclonal
Application: ELISA ; FACS ; IHC ; IP ; WB
Reactivity: Human
Host: Mouse
£300.00
This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.
Contributor
Inventor: Bernhard B. Singer
Institute: LeukoCom
Tool Details
*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)
- Name: Anti-CEACAM1/3/5/6 (CD66a/d/e/c) [D2-4H]
- Research fields: Cancer;Immunology
- Tool sub type: Primary antibody
- Class: Monoclonal
- Conjugation: Unconjugated
- Reactivity: Human
- Host: Mouse
- Application: ELISA ; FACS ; IHC ; IP ; WB
- Immunogen: Human CEA derivative
- Isotype: IgG1 kappa
- Myeloma used: NS1/0
Target Details
- Target: Human CEACAM 1, 3, 4, 6
Applications
- Application: ELISA ; FACS ; IHC ; IP ; WB
Handling
- Format: Liquid
- Concentration: 0.9-1.1 mg/ml
- Unit size: 100 ug
- Storage buffer: PBS with 0.02% azide
- Storage conditions: -15° C to -25° C
- Shipping conditions: Dry ice
References
- 1.) Singer B.B.: CEACAMs. Encyclopedia of Signaling Molecules. 2016.
- Javaheri et al. 2016. Nat Microbiol. 2:16189. PMID: 27748768.
- Helicobacter pylori adhesin HopQ engages in a virulence-enhancing interaction with human CEACAMs.
- Beauchemin et al. 2013. Cancer Metastasis Rev. 32(3-4):643-71. PMID: 23903773.
- Carcinoembryonic antigen-related cell adhesion molecules (CEACAMs) in cancer progression and metastasis.
